NCT05818683 2026-04-13A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerJanssen Research & Development, LLCPhase 1 Recruiting300 enrolled
NCT05413421 2025-08-11Study of ORIC-944 in Patients With Metastatic Prostate CancerORIC PharmaceuticalsPhase 1 Recruiting250 enrolled